Stay updated on M7824 and Topotecan in Relapsed SCLC Clinical Trial
Sign up to get notified when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.

Latest updates to the M7824 and Topotecan in Relapsed SCLC Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded the term Small cell lung carcinoma to the glossary and introduced a Resources section featuring the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0. No visible changes to study details or page functionality.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check68 days agoChange Detected- Revision metadata updated: added v3.4.2 and removed v3.4.1; no changes to the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check75 days agoChange Detected- Revision: v3.4.1 replaces v3.4.0 on the page. This is a minor site maintenance update with no changes to study details or user actions.SummaryDifference0.0%

Stay in the know with updates to M7824 and Topotecan in Relapsed SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.